Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
about
Serological detection of cutaneous T-cell lymphoma-associated antigensHaploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell deathDifferentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosisSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaExtracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.Immunomodulators in the treatment of cutaneous lymphoma.Cutaneous T-cell Lymphoma.Diverse cutaneous manifestations associated with a single disease.Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programExtracorporeal photophoresis: an evidence-based analysisEmerging drugs in cutaneous T-cell lymphomas.Staging and management of cutaneous T-cell lymphoma.Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?The diagnosis, staging, and treatment options for mycosis fungoides.The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.Phototherapy of mycosis fungoides.Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphoma.Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma.Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome.A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.Treatment of cutaneous T-cell lymphoma with alitretinoin gel.Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.An elderly patient with mycosis fungoides successfully treated with chronic low-dose oral etoposide therapy.Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab.Complete remission of previously intractable peripheral cutaneous T-cell lymphoma of the lower extremity using isolated hyperthermic limb perfusion with melphalan (1-phenylalanine mustard).Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.[Cutaneous lymphomas: classification and stage-adjusted therapy].Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases.
P2860
Q24544114-C69CDAEB-7A9F-4C19-B63F-FE7F062521A6Q24685820-2DC7DA82-183C-4295-BBE1-DBEC9F9FE22EQ28569870-C3966F70-BA64-47F5-BBB2-42C93F49CDD0Q30239965-56DA9445-825F-4307-B035-22DC4EFFADC9Q33358735-B4AB72B5-A841-443C-B97E-76F0ABBF7111Q33386623-6FE76768-160D-4CA4-999D-1C8298692564Q33762719-D3B0677B-A23F-4FDD-9A1B-A90DEE189151Q33777200-56DE2019-9DF4-4BB9-86EA-A8E50CC37C3AQ33889220-245F6F3F-7B1B-4568-9794-74FF75DC69ACQ34116799-6657EFE7-15F8-46E1-8176-D2FF94B35459Q34571940-77CA1878-6E11-4405-91B0-FAB06BF445B5Q36046989-DE310709-2679-470F-8667-E16617B5396FQ36150634-FAB02856-5E75-483E-B893-40EF44E00132Q36399825-4B239740-98E0-4B9F-93C8-254878F748CDQ36459144-FD3842EA-745E-4CD3-A19B-AC2CD31C921AQ36697663-16D99C76-41E2-4A4E-9EC2-F79238CD1187Q36771218-27F64AA7-3AF0-4B88-8193-D4A9558E2F03Q36802272-66254AE6-0E52-4D1F-B9BF-8FE447584B6BQ36870654-6898C944-A886-48C7-B98A-5C2803C79173Q36963163-CD9F873B-2B1D-41E7-8468-C9459C9569D2Q37109167-8BD8AF8D-7694-4FD5-8836-8041A36FBD06Q37323004-B6724BEB-E3C1-40A6-BEEE-E0D295F1F47EQ37851562-042D70AA-B19F-4518-80BF-A12ADEEB46D2Q38042561-51DAF636-E07C-4EF0-8AEE-F0C4998CCD34Q38286313-E7400024-8562-4D16-AECA-55AA150DA0BFQ40528057-8D37F8AC-3242-43F0-AD97-76AC181DA8C9Q40637906-460E3E56-9AFE-4E14-BE6D-517EC0B298B2Q43612578-7466999B-7FA8-4C89-8943-0D7BDDA54D2FQ43975407-4DDE423C-4CFA-4D9D-817B-E715559BD7C0Q44723870-84681070-38C5-4834-BCF1-4020150EA5C5Q44728253-9DA71F10-7F13-4240-AADC-D8D66ACDB848Q44876219-04ACE0EB-FF36-4532-8C15-2EC8751F963DQ45164038-D10AD3EB-AA95-42AB-8AD7-3E19D251D5F5Q46061398-4F056BE8-5DAA-4ED9-884C-F3B98E9ACF02Q46572255-72FD97B9-9355-4B10-B776-1F5C283FCE10Q46799392-BF7D9665-D6DC-4E56-94F0-DCE51BE6904DQ47898250-A11FD7B2-F022-45DB-870C-0A6D07F597E3Q48699469-9C9F7A88-C6F8-41B5-8657-290E5949181DQ52767066-866C97EE-C9F8-4FB2-8675-81A88AAD805AQ53417132-DD293BEB-6E4F-4AAE-984C-5EE5172DE0AB
P2860
Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@ast
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@en
Systemic therapy of cutaneous T-cell lymphomas
@nl
type
label
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@ast
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@en
Systemic therapy of cutaneous T-cell lymphomas
@nl
prefLabel
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@ast
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@en
Systemic therapy of cutaneous T-cell lymphomas
@nl
P2093
P1476
Systemic therapy of cutaneous ...... ides and the Sézary syndrome).
@en
P2093
P304
P356
10.7326/0003-4819-121-8-199410150-00007
P407
P577
1994-10-01T00:00:00Z